• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study.

作者信息

Torres A, Dorca J, Zalacaín R, Bello S, El-Ebiary M, Molinos L, Arévalo M, Blanquer J, Celis R, Iriberri M, Prats E, Fernández R, Irigaray R, Serra J

机构信息

Servei de Pneumologia i Al.lèrgia Respiratòria, Hospital Clínic, Universitat de Barcelona, Spain.

出版信息

Am J Respir Crit Care Med. 1996 Nov;154(5):1456-61. doi: 10.1164/ajrccm.154.5.8912764.

DOI:10.1164/ajrccm.154.5.8912764
PMID:8912764
Abstract

Community-acquired pneumonia (CAP) is an infectious illness that frequently motivates hospital admission when comorbid conditions are present. However, the epidemiology of CAP in relation to the underlying disease of the patients is not well known. We performed a prospective multicenter study with the aim of assessing the clinical characteristics, etiology, and outcome of chronic obstructive pulmonary disease (COPD) patients with CAP. Between October 1992 and December 1994 we studied 124 COPD patients (mean FEV1 40 +/- 11% of predicted, mean FVC/FEV1 49 +/- 10) admitted because of CAP to one of the participating centers. An attempt to obtain an etiologic diagnosis was performed by means of blood cultures (n = 123), sputum cultures (n = 97), pleural fluid cultures (n = 17), protected specimen brush samples (n = 41), percutaneous transthoracic needle aspiration (n = 41), and serology (n = 106). Etiologic diagnosis was achieved in 80 (64%) of cases, however, diagnosis based upon valid techniques was only possible in 73 (59%) cases. The main causal microorganisms were the following: Streptococcus pneumoniae in 32 (43%), Chlamydia pneumoniae in 9 (12%), Hemophilus influenzae in 7 (9%), Legionella pneumophila in 7 (9%), Streptococcus viridans in 3 (4%), Coxiella burnetii in 3 (4%), Mycoplasma pneumoniae in 2 (3%), Nocordia asteroides 2, Aspergillus ssp. 1, and others 10. In three of these cases the etiology was polymicrobial. Bacteremia was present in 19 (15%) cases; S. pneumoniae was the most frequent isolate (13 cases). Antibiotic treatment was modified in 22 cases due to etiologic findings, and in 9 due to therapeutic failure. Ten patients died (8%), and 22 needed mechanical ventilation, the mortality rate in the latter population being 23%. Total or partial resistance of S. pneumoniae to penicillin was observed in 10 of 32 (31%) isolations, and to erythromycin in 2 (6%). The results of this study are important for the standardization of empiric antibiotic strategies in COPD patients with pneumonia.

摘要

相似文献

1
Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study.
Am J Respir Crit Care Med. 1996 Nov;154(5):1456-61. doi: 10.1164/ajrccm.154.5.8912764.
2
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.社区获得性肺炎的病因:年龄、合并症及严重程度的影响
Am J Respir Crit Care Med. 1999 Aug;160(2):397-405. doi: 10.1164/ajrccm.160.2.9808045.
3
[Investigation of bacterial etiology with conventional and multiplex PCR methods in adult patients with community-acquired pneumonia].[采用传统及多重PCR方法对成人社区获得性肺炎患者进行细菌病因学调查]
Mikrobiyol Bul. 2012 Oct;46(4):523-31.
4
[A multicentre study on the pathogenic agents in 665 adult patients with community-acquired pneumonia in cities of China].[中国城市665例成人社区获得性肺炎病原菌的多中心研究]
Zhonghua Jie He He Hu Xi Za Zhi. 2006 Jan;29(1):3-8.
5
[Clinical and etiological features of community-acquired pneumonia in the elderly].[老年人社区获得性肺炎的临床及病因学特征]
Enferm Infecc Microbiol Clin. 1994 Jan;12(1):21-5.
6
[Prognostic factors and etiology in patients with severe community-acquired pneumonia admitted at the ICU. Spanish multicenter study. Study Group on Severe Community-Acquired Pneumonia in Spain].[重症监护病房收治的重症社区获得性肺炎患者的预后因素及病因。西班牙多中心研究。西班牙重症社区获得性肺炎研究组]
Med Clin (Barc). 1998 Nov 21;111(17):650-4.
7
Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan.台湾地区需住院治疗的成年社区获得性肺炎患者的病因
Respir Med. 2005 Sep;99(9):1079-86. doi: 10.1016/j.rmed.2005.02.026. Epub 2005 Apr 18.
8
The incidence and etiology of community-acquired pneumonia in fever outpatients.发热门诊社区获得性肺炎的发病及病因。
Exp Biol Med (Maywood). 2012 Nov;237(11):1256-61. doi: 10.1258/ebm.2012.012014.
9
Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.成人社区获得性肺炎住院患者中“非典型病原体”的作用。
Respirology. 2009 Nov;14(8):1098-105. doi: 10.1111/j.1440-1843.2009.01637.x. Epub 2009 Oct 5.
10
The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness.城市公立医院社区获得性肺炎的病因:人类免疫缺陷病毒感染及疾病初始严重程度的影响
J Infect Dis. 2001 Aug 1;184(3):268-77. doi: 10.1086/322040. Epub 2001 Jun 26.

引用本文的文献

1
Pathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness.危重病中肠道微生物失调的发病机制和治疗机会。
Gut Microbes. 2024 Jan-Dec;16(1):2351478. doi: 10.1080/19490976.2024.2351478. Epub 2024 May 23.
2
[Guidelines for the management of community pneumonia in adult who needs hospitalization].[成人社区获得性肺炎住院治疗管理指南]
Med Intensiva. 2005 Feb;29(1):21-62. doi: 10.1016/S0210-5691(05)74199-1. Epub 2009 Jan 6.
3
Community-acquired pneumonia and its predictors of mortality in rural southwestern Nigeria: A-five year retrospective observational study.
尼日利亚西南部农村地区社区获得性肺炎及其死亡率预测因素:一项为期五年的回顾性观察研究。
Afr J Emerg Med. 2022 Sep;12(3):293-297. doi: 10.1016/j.afjem.2022.04.011. Epub 2022 Jun 24.
4
Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis.南欧(西班牙、葡萄牙、意大利和希腊)成年人中肺炎球菌病的负担:系统评价和荟萃分析。
Hum Vaccin Immunother. 2021 Oct 3;17(10):3670-3686. doi: 10.1080/21645515.2021.1923348. Epub 2021 Jun 9.
5
Healthcare-associated pneumonia: a prospective study in Spain.医疗机构相关性肺炎:西班牙的一项前瞻性研究。
Rev Esp Quimioter. 2020 Oct;33(5):358-368. doi: 10.37201/req/067.2020. Epub 2020 Jul 22.
6
Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists.Nrf2 激动剂增强慢性阻塞性肺疾病的调理吞噬作用。
Am J Respir Crit Care Med. 2018 Sep 15;198(6):739-750. doi: 10.1164/rccm.201705-0903OC.
7
Risk Factors for Pneumonia and the Effect of the Pneumococcal Vaccine in Patients With Chronic Airflow Obstruction.慢性气流受限患者肺炎的危险因素及肺炎球菌疫苗的作用
Chronic Obstr Pulm Dis. 2016 Jun 1;3(3):610-619. doi: 10.15326/jcopdf.3.3.2015.0167.
8
Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease Macrophages.慢性阻塞性肺疾病巨噬细胞中线粒体杀菌反应受损。
Am J Respir Crit Care Med. 2017 Oct 1;196(7):845-855. doi: 10.1164/rccm.201608-1714OC.
9
Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.慢性阻塞性肺疾病(COPD)患者社区获得性肺炎的季节性、危险因素及负担:一项使用关联医疗记录的人群数据库研究
Int J Chron Obstruct Pulmon Dis. 2017 Jan 17;12:313-322. doi: 10.2147/COPD.S121389. eCollection 2017.
10
Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.用于预防慢性阻塞性肺疾病患者肺炎的肺炎球菌疫苗。
Cochrane Database Syst Rev. 2017 Jan 24;1(1):CD001390. doi: 10.1002/14651858.CD001390.pub4.